GSK to Sell Its 2.5% Stake in Haleon
11 Maio 2023 - 1:25PM
Dow Jones News
By Michael Susin
GSK said Thursday that it will sell its stake in Haleon via a
placing to institutional investors.
The pharmaceutical major said it intends to sell up to 240
million shares, the equivalent of up to 2.5% of Haleon's issued
share capital.
The company said the offer price will be determined by means of
an accelerated bookbuild process, which is to start
immediately.
Haleon is a consumer-healthcare business which was spun out of
GSK and is partly owned by Pfizer, which currently holds a 32%
stake in Haleon.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
May 11, 2023 12:10 ET (16:10 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Gsk (LSE:GSK)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
